Machine Learning

A Chinese biotech is pioneering next-gen cancer drugs that promise higher precision and fewer side effects. Is this the future of oncology treatment?

Denali Therapeutics raises $200M to advance its brain-penetrating drugs, betting big on its pipeline despite short-term market jitters.

A 1.01 Tbps cyberattack was just a skirmish in a wider war. See how advanced AI and massive defenses are the new front line against digital extortion.

Gossamer Bio's recent 200,000-share grant to a new hire is more than a welcome bonus; it's a strategic bet on its blockbuster drug candidate.

As EMEA faces a critical tech skills shortage, Skillsoft’s AWS award reveals a proven blueprint for building the cloud and AI workforce of the future.

CEO Amy Perry’s influence is celebrated, but her true test is securing Banner’s vast, AI-driven ecosystem from the escalating threats of the digital age.

Beyond a simple payout, Qnity Electronics' increased dividend reveals its deep financial strength and strategic position fueling the AI and HPC revolution.

The creator economy has mastered ROI-driven engagement. Can healthcare use its AI-powered playbook to improve patient outcomes and combat misinformation?

CEO Adrian Mendes' major buy-in signals deep confidence as Perimeter Medical AI navigates FDA approval for its game-changing cancer surgery technology.

A prestigious Yale recognition for board member Dr. Curtis Patton bolsters Tevogen's credibility as it advances its AI and T-cell platforms.

A new software-defined radio isn't just a product launch; it's a strategic masterstroke, embracing open standards to reshape electronic warfare and investment.

A California fragrance brand conquered Korea and now targets the U.S. We dissect the data-driven strategy and AI's quiet role in its rapid rise.

A new platform lets your idle devices earn Bitcoin. Is this a futuristic lifestyle trend for luxury living or just a volatile digital experiment?

A landmark deal between Airspan and Rakuten, backed by US funds, marks a new era for open networks, challenging the global telecom supply chain.

PathAI's AIM-MASH tool just got dual FDA/EMA approval, a first for AI pathology. This could slash MASH drug development time and reshape clinical trials.

Beyond a tagline, The Aesthetic Society is expanding to include non-surgeons, a strategic move to set standards and consolidate influence in a booming market.

Ekinops unveils its C700HC chassis, a hybrid system designed to unify telecom offices and data centers, tackling the massive bandwidth demands of AI.

Cleric's new AI SRE agent promises to end engineering firefighting by learning from incidents. With $9.8M in funding, is this the future of system reliability?

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

Black Friday’s record-breaking data demands reveal a blueprint for healthcare's own looming data crisis. What can medicine learn from retail's tech engine?